Global Digital PCR Market By Technology (Droplet Digital PCR, Chip Based Digital PCR, Beaming Digital PCR), By Product Type(digital PCR Systems, Consumables, And Reagents, Software And Services), By Application (Clinical Diagnostics, Forensic And Others, Research), By End User (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities, And Other Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa) – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2030

Global Digital PCR Market Overview

Digital PCR is an end-point PCR method for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. Digital PCR (dPCR) allows for precise and sensitive nucleic acid measurement. Because the amplified result is identified by agarose gel electrophoresis, traditional PCR is a semi-quantitative end-point analysis. Real-time PCR (or qPCR) uses fluorescence-based detection to track the amount of amplified product that has accumulated as the reaction advances.

Only relative quantification is possible with qPCR because it requires normalization to controls or a standard curve. Variations in amplification efficiency may also influence qPCR results. Droplet digital PCR, chip-based digital PCR, and beamed digital PCR are the three types of digital PCR.

Although digital PCR applications benefit the molecular biology industry, the high price associated with high-tech digital PCR devices function as a stumbling block when compared to the cost of RT-PCR. Furthermore, despite the fact that digital PCR is gaining popularity, demand for real-time PCR remains strong in applications like as genotyping and gene expression studies, owing to the lower cost of RT PCR.

Furthermore, rising competition in Next Generation Sequencing (NGS), which is used to sequence whole genomes, full exomes, transcriptomes, and specific gene sections, is a factor contributing to the decline in demand for digital PCR. Because targeted next-generation sequencing is more cost-effective, the digital polymerase chain reaction market's growth may be limited.
 

Market Size

According to Business Intelligence Insights "Digital PCR market is expected to grow from USD 562.10 million in 2021 to USD 1063.75 million by 2028, at a CAGR of 8.30% during the forecast period 2022-2030.

Covid -19 Impact Analysis

In numerous sections of the healthcare business, the impact of the COVID-19 pandemic was measured. Diagnostics was the most affected industry. The COVID-19 pandemic had a positive impact on the growth of RT-PCR and digital PCR, both of which are used in diagnostics and drug discovery. The development of novel droplet digital PCR kits for the detection of COVID-19 is a major industrial priority. The diagnostics industry was the hardest hit, with a significant increase in the PCR market. As they are used for diagnostic and drug discovery, digital PCR and real-time PCR have seen a lot of interest. Industry vendors are increasingly focusing on developing droplet digital PCR kits to detect COVID-19. Regulatory agencies have expressed strong support for approving these tests in order to mitigate the effects of the COVID-19 pandemic

Market Dynamics

Drivers

• Investments, finances, and awards are increasing.
• Infectious Diseases and Cancer are on the Rise

Restraints

• Digital PCR devices are expensive.
• Inadequate technical knowledge to operate the instrument
   

Segmentation Insights

By Technology 

The Droplet Digital PCR category dominated the market with more than 33% of the market share

In 2021, the market for Digital PCR was dominated by Droplet Digital PCR as a technology.  Droplet digital PCR (ddPCR) is a digital PCR method that utilizes water-oil emulsion droplet technology. A sample is divided into 20,000 droplets, with each droplet undergoing PCR amplification of the template molecules. The reagents and procedures utilized in ddPCR are identical to those used in most TaqMan probe-based experiments. The ddPCR technology relies heavily on enormous sample partitioning. Apart from the ddPCR's advantages, drivers driving the segment's growth include the rising prevalence of cancer and infectious diseases, as well as increased financing and advancements in the biotechnology sector. 

By Application 

The Research category dominated the market with more than 35% of the market share

The mode of application in which Digital PCR can be taken is Clinical Diagnostics, Forensic And Others, and Research. In the worldwide Digital PCR industry, Research is the most popular application mode. qPCR analysis is a commonly used approach in research, particularly in gene-based research to find gene aberrations and mutations, identify specific genetic markers in oncology and genomic investigations, and drug screening and lead identification in drug discovery. The growing trend of qPCR-based research data publication, expanding qPCR-based genomic investigations, and the continuing trend of laboratory automation and robotics integration with qPCR processes all promote this market segment's growth. 

 

By Technology 

• Droplet Digital PCR 
• Chip Based Digital PCR
• Beaming Digital PCR

By Product Type

• Digital PCR Systems 
• Consumables And Reagents 
• Software And Services

By Application 

• Clinical Diagnostics 
• Forensic And Others 
• Research

By End User 

• Pharmaceuticals And Biotechnology Industries 
• Clinical Diagnostic Laboratories 
• Universities And Other Organizations

By Region

• North America
• U.S.
• Canada
• Europe 
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific 
• China
• India
• Japan
• Rest of Asia Pacific
• Latin America 
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa 
• UAE
• South Africa
• Rest of Middle East and Africa (MEA)

Key Players

• Avance Biosciences, 
• Bio-Rad Laboratories, Inc. 
• Fluidigm Corporation,  
• Jn medsys,  
• Merck KGAA,  
• Precigenome LLC, 
• QIAGEN N.V,  
• STILLA TECHNOLOGIES, 
•  Sysmex corporation, 
• Thermo Fisher Scientific, Inc.  
   

Regional Insights

North America dominated the market with more than 30% of the market share

The presence of important companies, the high frequency of chronic diseases in the region, and the developed healthcare infrastructure are all contributing to market expansion. Furthermore, favorable government efforts and an increase in the number of research partnerships are projected to propel the industry forward. Due to favorable healthcare legislation, a large number of patients, and a developed healthcare market, the United States has the largest share in this region.
 

Table

Report Attributes	Details
Market Size Value in 2021	USD 562.10 million
Market Size Value in 2030	USD 1063.75 million
Growth Rate	8.30%
Base Year	2021
Forecast Period	2022-2030
Historical Data	2018-2020
Forecast Units	(USD million)
Countries Covered	North America: U.S and Canada Europe: Germany, France, Italy, U.K, Spain, Russia, Rest of Europe APAC: China, Japan, South Korea, India, Australia, South East Asia, Rest of Asia Pacific Latin America: Brazil, Mexico Middle East And Africa: Saudi Arab, South Africa, UAE
Segments Covered	By Technology ,By Product Type, By Application , By End User , By Region
Competitive landscape	Leading companies, Competitive strategies and Consumer engagement scope
Customization is available	If our report does not contain the information you require, you can contact our experts to have segments created for you. Please contact us at sales@businessintelligence-insights.com if you have any questions

 

Frequently Asked Questions (FAQ):